{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T12:09:37Z","timestamp":1781006977810,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-025-11385-3","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T05:43:13Z","timestamp":1766986993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Functional genetic variants in immune-checkpoint molecules and susceptibility to Nasopharyngeal carcinoma in a Tunisian case-control study"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6230-6116","authenticated-orcid":false,"given":"Wejden","family":"Gharbi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wicem","family":"Siala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olfa","family":"Abida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bassem","family":"Lahiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan","family":"Feki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikram","family":"Ben Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamel","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatem","family":"Masmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hend","family":"Hachicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"11385_CR1","unstructured":"Chan JKC, Pilch BZ, Kuo TT, Wenig BM, Lee AWM (2005) Tumours of the nasopharynx. In: Barnes L, Eveson JW, Reichart P, Sidransky D (eds) Head and neck tumours. Lyon IARC, pp 81\u2013106"},{"key":"11385_CR2","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1016\/j.ejca.2010.04.004","volume":"46","author":"ARA Razak","year":"2010","unstructured":"Razak ARA, Siu LL, Liu FF, Ito E, O\u2019Sullivan B, Chan K (2010) Nasopharyngeal carcinoma: the next challenges. Eur J Cancer 46:1967\u20131978. https:\/\/doi.org\/10.1016\/j.ejca.2010.04.004","journal-title":"Eur J Cancer"},{"key":"11385_CR3","unstructured":"Cancer (IARC) (2022) Global Cancer Observatory. https:\/\/gco.iarc.fr\/"},{"key":"11385_CR4","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1007\/s00405-021-06628-5","volume":"278","author":"A Laribi","year":"2021","unstructured":"Laribi A, Aouf S, Gabbouj S, Bouaouinaa N, Zakhama A, Harizi H (2021) Human glutathione peroxidase codon 198 variant increases nasopharyngeal carcinoma risk and progression. Eur Arch Otorhinolaryngol 278:4027\u20134034. https:\/\/doi.org\/10.1007\/s00405-021-06628-5","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"11385_CR5","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/S0959-8049(03)00512-4","volume":"39","author":"J Daoud","year":"2003","unstructured":"Daoud J, Toumi N, Bouaziz M, Ghorbel A, Jlidi R, Drira MM, Frikha M (2003) Nasopharyngeal carcinoma in childhood and adolescence: analysis of a series of 32 patients treated with combined chemotherapy and radiotherapy. Eur J Cancer 39:2349\u20132354. https:\/\/doi.org\/10.1016\/S0959-8049(03)00512-4","journal-title":"Eur J Cancer"},{"key":"11385_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.canrad.2006.05.004","volume":"10","author":"A Khanfir","year":"2006","unstructured":"Khanfir A, Frikha M, Ghorbel A, Karray H, Drira MM, Daoud J (2006) Les cancers m\u00e9tastatiques du nasopharynx: \u00e9tude clinique et r\u00e9sultats th\u00e9rapeutiques de 95 Cas. Cancer\/Radioth\u00e9rapie 10:545\u2013549. https:\/\/doi.org\/10.1016\/j.canrad.2006.05.004","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"11385_CR7","doi-asserted-by":"publisher","first-page":"e690","DOI":"10.1002\/iid3.690","volume":"10","author":"S Souissi","year":"2022","unstructured":"Souissi S, Ghedira R, Macherki Y, Ben-Haj-Ayed A, Gabbouj S, Remadi Y et al (2022) Indoleamine 2,3-dioxygenase gene expression and kynurenine to Tryptophan ratio correlation with nasopharyngeal carcinoma progression and survival. Immun Inflamm Dis 10:e690. https:\/\/doi.org\/10.1002\/iid3.690","journal-title":"Immun Inflamm Dis"},{"key":"11385_CR8","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1038\/sj.bjc.6605281","volume":"101","author":"B-J Feng","year":"2009","unstructured":"Feng B-J, Khyatti M, Ben-Ayoub W, Dahmoul S, Ayad M, Maachi F et al (2009) Cannabis, tobacco and domestic fumes intake are associated with nasopharyngeal carcinoma in North Africa. Br J Cancer 101:1207\u20131212. https:\/\/doi.org\/10.1038\/sj.bjc.6605281","journal-title":"Br J Cancer"},{"key":"11385_CR9","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.oraloncology.2014.02.006","volume":"50","author":"SW Tsao","year":"2014","unstructured":"Tsao SW, Yip YL, Tsang CM, Pang PS, Lau VM, Zhang G, Lo KW (2014) Etiological factors of nasopharyngeal carcinoma. Oral Oncol 50:330\u2013338. https:\/\/doi.org\/10.1016\/j.oraloncology.2014.02.006","journal-title":"Oral Oncol"},{"key":"11385_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2015.10.009","volume":"39","author":"DH Munn","year":"2016","unstructured":"Munn DH, Bronte V (2016) Immune suppressive mechanisms in the tumor microenvironment. Curr Opin Immunol 39:1\u20136. https:\/\/doi.org\/10.1016\/j.coi.2015.10.009","journal-title":"Curr Opin Immunol"},{"key":"11385_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12943-018-0928-4","volume":"18","author":"X Jiang","year":"2019","unstructured":"Jiang X, Wang J, Deng X, Xiong F, Ge J, Xiang B et al (2019) Role of the tumor microenvironment in PD-L1\/PD-1-mediated tumor immune escape. Mol Cancer 18:10. https:\/\/doi.org\/10.1186\/s12943-018-0928-4","journal-title":"Mol Cancer"},{"key":"11385_CR12","doi-asserted-by":"publisher","first-page":"364","DOI":"10.5301\/jbm.5000170","volume":"30","author":"S Cheng","year":"2015","unstructured":"Cheng S, Zheng J, Zhu J, Xie C, Zhang X, Han X et al (2015) PD-L1 gene polymorphism and high level of plasma soluble PD-L1 protein May be associated with non-small cell lung cancer. Int J Biol Markers 30:364\u2013368. https:\/\/doi.org\/10.5301\/jbm.5000170","journal-title":"Int J Biol Markers"},{"key":"11385_CR13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.prp.2018.12.002","volume":"215","author":"J Zou","year":"2019","unstructured":"Zou J, Wu D, Li T, Wang X, Liu Y, Tan S (2019) Association of PD-L1 gene rs4143815 C\u2009>\u2009G polymorphism and human cancer susceptibility: A systematic review and meta-analysis. Pathol - Res Pract 215:229\u2013234. https:\/\/doi.org\/10.1016\/j.prp.2018.12.002","journal-title":"Pathol - Res Pract"},{"key":"11385_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1146\/annurev.immunol.24.021605.090535","volume":"24","author":"WA Teft","year":"2006","unstructured":"Teft WA, Kirchhof MG, Madrenas J (2006) A molecular perspective of CTLA-4 function. Annu Rev Immunol 24:65\u201397. https:\/\/doi.org\/10.1146\/annurev.immunol.24.021605.090535","journal-title":"Annu Rev Immunol"},{"key":"11385_CR15","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/COC.0000000000000239","volume":"39","author":"EI Buchbinder","year":"2016","unstructured":"Buchbinder EI, Desai A (2016) CTLA-4 and PD-1 pathways: Similarities, Differences, and implications of their Inhibition. Am J Clin Oncol 39:98\u2013106. https:\/\/doi.org\/10.1097\/COC.0000000000000239","journal-title":"Am J Clin Oncol"},{"key":"11385_CR16","doi-asserted-by":"publisher","first-page":"1198365","DOI":"10.3389\/fimmu.2023.1198365","volume":"14","author":"MM Hossen","year":"2023","unstructured":"Hossen MM, Ma Y, Yin Z, Xia Y, Du J, Huang JY et al (2023) Current Understanding of CTLA-4: from mechanism to autoimmune diseases. Front Immunol 14:1198365. https:\/\/doi.org\/10.3389\/fimmu.2023.1198365","journal-title":"Front Immunol"},{"key":"11385_CR17","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.4049\/jimmunol.147.3.1037","volume":"147","author":"K Harper","year":"1991","unstructured":"Harper K, Balzano C, Rouvier E, Matt\u00e9i MG, Luciani MF, Golstein P (1991) CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol 147:1037\u20131044. https:\/\/doi.org\/10.4049\/jimmunol.147.3.1037","journal-title":"J Immunol"},{"key":"11385_CR18","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.cancergen.2016.06.006","volume":"209","author":"R-M Zhou","year":"2016","unstructured":"Zhou R-M, Li Y, Wang N, Huang X, Cao SR, Shan BE (2016) Association of programmed death-1 polymorphisms with the risk and prognosis of esophageal squamous cell carcinoma. Cancer Genet 209:365\u2013375. https:\/\/doi.org\/10.1016\/j.cancergen.2016.06.006","journal-title":"Cancer Genet"},{"key":"11385_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/ni1443","volume":"8","author":"AH Sharpe","year":"2007","unstructured":"Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ (2007) The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8:239\u2013245. https:\/\/doi.org\/10.1038\/ni1443","journal-title":"Nat Immunol"},{"key":"11385_CR20","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1006\/geno.1994.1562","volume":"23","author":"T Shinohara","year":"1994","unstructured":"Shinohara T, Taniwaki M, Ishida Y, Kawaichi M, Honjo T (1994) Structure and chromosomal localization of the human PD-1 gene (PDCD1). Genomics 23:704\u2013706. https:\/\/doi.org\/10.1006\/geno.1994.1562","journal-title":"Genomics"},{"key":"11385_CR21","unstructured":"Brierley J, Giuliani M, O\u2019Sullivan B, Rous B, Eycken EV (2009) International union against cancer (UICC) TNM: classification of malignant tumours. Oesophagus Oesophagogastric Junction.7th edition : 66\u201372"},{"key":"11385_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1744-313X.2009.00888.x","volume":"37","author":"M Xiao","year":"2010","unstructured":"Xiao M, Qi F, Chen X et al (2010) Functional polymorphism of cytotoxic T-lymphocyte antigen 4 and nasopharyngeal carcinoma susceptibility in a Chinese population. Int J Immunogenet 37:27\u201332. https:\/\/doi.org\/10.1111\/j.1744-313X.2009.00888.x","journal-title":"Int J Immunogenet"},{"key":"11385_CR23","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.humimm.2010.05.023","volume":"71","author":"L Hu","year":"2010","unstructured":"Hu L, Liu J, Chen X, Luo Z, Zhang L, Zheng C et al (2010) CTLA-4 gene polymorphism\u2009+\u200949 A\/G contributes to genetic susceptibility to two infection-related cancers\u2014hepatocellular carcinoma and cervical cancer. Hum Immunol 71:888\u2013891. https:\/\/doi.org\/10.1016\/j.humimm.2010.05.023","journal-title":"Hum Immunol"},{"key":"11385_CR24","doi-asserted-by":"publisher","first-page":"874","DOI":"10.3390\/genes14040874","volume":"14","author":"N Al-Harbi","year":"2023","unstructured":"Al-Harbi N, Abdulla M-H, Vaali-Mohammed M-A, Bin Traiki T, Alswayyed M, Al-Obeed O et al (2023) Evidence of association between CTLA-4 gene polymorphisms and colorectal cancers in Saudi patients. Genes 14:874. https:\/\/doi.org\/10.3390\/genes14040874","journal-title":"Genes"},{"key":"11385_CR25","first-page":"11519","volume":"8","author":"H-N Liu","year":"2015","unstructured":"Liu H-N, Su J-L, Zhou S-H, Liu LJ, Qie P (2015) Cytotoxic T lymphocyte-associated antigen-4\u2009+\u200949A\u2009>\u2009G polymorphism and the risk of non-small cell lung cancer in a Chinese population. Int J Clin Exp Med 8:11519\u201311523","journal-title":"Int J Clin Exp Med"},{"key":"11385_CR26","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.4103\/0973-1482.203604","volume":"14","author":"C Wang","year":"2018","unstructured":"Wang C, Liu W, Zhao L, Dong Z (2018) Association of cytotoxic T-lymphocyte antigen-4\u2009+\u200949A\/G gene polymorphism with hepatocellular carcinoma risk in Chinese. J Cancer Res Ther 14:1117. https:\/\/doi.org\/10.4103\/0973-1482.203604","journal-title":"J Cancer Res Ther"},{"key":"11385_CR27","first-page":"188","volume":"9","author":"N Erfani","year":"2012","unstructured":"Erfani N, Haghshenas MR, Hoseini MA, Hashemi SB, Khademi B, Ghaderi A (2012) Strong association of CTLA-4 variation (CT60A\/G) and CTLA-4 haplotypes with predisposition of Iranians to head and neck cancer. Iran J Immunol IJI 9:188\u2013198","journal-title":"Iran J Immunol IJI"},{"key":"11385_CR28","doi-asserted-by":"publisher","first-page":"993581","DOI":"10.3389\/fams.2022.993581","volume":"8","author":"I Azarov","year":"2022","unstructured":"Azarov I, Helmlinger G, Kosinsky Y, Peskov K (2022) Elaborating on anti CTLA-4 mechanisms of action using an agent-based modeling approach. Front Appl Math Stat 8:993581. https:\/\/doi.org\/10.3389\/fams.2022.993581","journal-title":"Front Appl Math Stat"},{"key":"11385_CR29","doi-asserted-by":"publisher","first-page":"46478","DOI":"10.1074\/jbc.M206894200","volume":"277","author":"S Anjos","year":"2002","unstructured":"Anjos S, Nguyen A, Ounissi-Benkalha H, Tessier MC, Polychronakos C (2002) A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem 277:46478\u201346486. https:\/\/doi.org\/10.1074\/jbc.M206894200","journal-title":"J Biol Chem"},{"key":"11385_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/513915","volume":"2014","author":"SM Abdel Galil","year":"2014","unstructured":"Abdel Galil SM, Hagrass HA (2014) The role of CTLA-4 exon-1 49 A\/G polymorphism and soluble CTLA-4 protein level in Egyptian patients with Beh\u00e7et\u2019s disease. BioMed Res Int 2014:1\u20136. https:\/\/doi.org\/10.1155\/2014\/513915","journal-title":"BioMed Res Int"},{"key":"11385_CR31","doi-asserted-by":"publisher","first-page":"6606","DOI":"10.4049\/jimmunol.165.11.6606","volume":"165","author":"T Kouki","year":"2000","unstructured":"Kouki T, Sawai Y, Gardine CA, Fisfalen ME, Alegre ML, DeGroot LJ (2000) CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of graves\u2019 disease. J Immunol 165:6606\u20136611. https:\/\/doi.org\/10.4049\/jimmunol.165.11.6606","journal-title":"J Immunol"},{"key":"11385_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00251-002-0429-9","volume":"54","author":"S M\u00e4urer","year":"2002","unstructured":"M\u00e4urer S, Loserth, Anne M (2002) A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1\u2009+\u200949) alters T-cell activation. Immunogenetics 54:1\u20138. https:\/\/doi.org\/10.1007\/s00251-002-0429-9","journal-title":"Immunogenetics"},{"key":"11385_CR33","doi-asserted-by":"publisher","first-page":"7025","DOI":"10.1158\/0008-5472.CAN-08-0806","volume":"68","author":"T Sun","year":"2008","unstructured":"Sun T, Zhou Y, Yang M, Hu Z, Tan W, Han X et al (2008) Functional genetic variations in cytotoxic T-lymphocyte antigen 4 and susceptibility to multiple types of cancer. Cancer Res 68:7025\u20137034. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-0806","journal-title":"Cancer Res"},{"key":"11385_CR34","doi-asserted-by":"publisher","first-page":"8433489","DOI":"10.1155\/2022\/8433489","volume":"2022","author":"G Wang","year":"2022","unstructured":"Wang G, Dong Y, Yang Y, Zhang W, Liu N, Wei Y (2022) PD-L1 rs2890658 polymorphism increases risk for Non\u2010Small\u2010Cell lung cancer in Northern China population based on experimental data and Meta\u2010Analysis. Contrast Media Mol Imaging 2022:8433489. https:\/\/doi.org\/10.1155\/2022\/8433489","journal-title":"Contrast Media Mol Imaging"},{"key":"11385_CR35","doi-asserted-by":"publisher","first-page":"6068","DOI":"10.18632\/aging.205689","volume":"16","author":"M Yang","year":"2024","unstructured":"Yang M, Liu Y, Zheng S, Geng P, He T, Lu L et al (2024) Associations of PD-1 and PD-L1 gene polymorphisms with cancer risk: a meta-analysis based on 50 studies. Aging 16:6068\u20136097. https:\/\/doi.org\/10.18632\/aging.205689","journal-title":"Aging"},{"key":"11385_CR36","first-page":"2130","volume":"13","author":"X Zhao","year":"2020","unstructured":"Zhao X, Peng Y, Li X, Zhang S, Peng Y, Shan J et al (2020) The association of PD-L1 gene polymorphisms with non-small-cell lung cancer susceptibility and clinical outcomes in a Chinese population. Int J Clin Exp Pathol 13:2130\u20132136","journal-title":"Int J Clin Exp Pathol"},{"key":"11385_CR37","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/ajco.12037","volume":"10","author":"Y Chen","year":"2014","unstructured":"Chen Y, Mu C, Chen C, Huang J (2014) Association between single nucleotide polymorphism of PD-L1 gene and non-small cell lung cancer susceptibility in a Chinese population. Asia Pac J Clin Oncol 10:e1\u2013e6. https:\/\/doi.org\/10.1111\/ajco.12037","journal-title":"Asia Pac J Clin Oncol"},{"key":"11385_CR38","doi-asserted-by":"publisher","first-page":"533","DOI":"10.31557\/APJCP.2025.26.2.533","volume":"26","author":"LA Hegazi","year":"2025","unstructured":"Hegazi LA, El-Masry MW, Gouda HM, Mattar MM, Hassan MT (2025) The genetic influence of programmed death Ligand-1 (PD-L1) single nucleotide polymorphisms on the incidence of B-Cell Non-Hodgkin lymphoma in a cohort of Egyptians. Asian Pac J Cancer Prev 26:533\u2013539. https:\/\/doi.org\/10.31557\/APJCP.2025.26.2.533","journal-title":"Asian Pac J Cancer Prev"},{"key":"11385_CR39","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1530\/EJE-07-0649","volume":"158","author":"M Hayashi","year":"2008","unstructured":"Hayashi M, Kouki T, Takasu N, Sunagawa S, Komiya I (2008) Association of an A\/C single nucleotide polymorphism in programmed cell death-ligand 1 gene with graves\u2019 disease in Japanese patients. Eur J Endocrinol 158:817\u2013822. https:\/\/doi.org\/10.1530\/EJE-07-0649","journal-title":"Eur J Endocrinol"},{"key":"11385_CR40","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.prp.2018.09.015","volume":"214","author":"L-S Da","year":"2018","unstructured":"Da L-S, Zhang Y, Zhang C-J, Bu L-J, Zhu Y-Z, Ma T, Gu K-S (2018) The PD-1 rs36084323 A\u2009>\u2009G polymorphism decrease cancer risk in asian: A meta-analysis. Pathol - Res Pract 214:1758\u20131764. https:\/\/doi.org\/10.1016\/j.prp.2018.09.015","journal-title":"Pathol - Res Pract"},{"key":"11385_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08820139.2018.1538235","volume":"48","author":"F Fathi","year":"2019","unstructured":"Fathi F, Faghih Z, Khademi B, Kayedi T, Erfani N, Gahderi A (2019) PD-1 haplotype combinations and susceptibility of patients to squamous cell carcinomas of head and neck. Immunol Invest 48:1\u201310. https:\/\/doi.org\/10.1080\/08820139.2018.1538235","journal-title":"Immunol Invest"},{"key":"11385_CR42","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.clinbiochem.2013.12.023","volume":"47","author":"H Qiu","year":"2014","unstructured":"Qiu H, Zheng L, Tang W, Yin P, Cheng F, Wang L (2014) Programmed death-1 (PD-1) polymorphisms in Chinese patients with esophageal cancer. Clin Biochem 47:612\u2013617. https:\/\/doi.org\/10.1016\/j.clinbiochem.2013.12.023","journal-title":"Clin Biochem"},{"key":"11385_CR43","doi-asserted-by":"publisher","first-page":"672521","DOI":"10.3389\/fimmu.2021.672521","volume":"12","author":"S Parakh","year":"2021","unstructured":"Parakh S, Musafer A, Paessler S et al (2021) PDCD1 polymorphisms May predict response to Anti-PD-1 Blockade in patients with metastatic melanoma. Front Immunol 12:672521. https:\/\/doi.org\/10.3389\/fimmu.2021.672521","journal-title":"Front Immunol"},{"key":"11385_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s10549-011-1440-3","volume":"129","author":"Z Hua","year":"2011","unstructured":"Hua Z, Li D, Xiang G, Xu F, Jie G, Fu Z et al (2011) PD-1 polymorphisms are associated with sporadic breast cancer in Chinese Han population of Northeast China. Breast Cancer Res Treat 129:195\u2013201. https:\/\/doi.org\/10.1007\/s10549-011-1440-3","journal-title":"Breast Cancer Res Treat"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11385-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-025-11385-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-025-11385-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T05:43:15Z","timestamp":1766986995000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-025-11385-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["11385"],"URL":"https:\/\/doi.org\/10.1007\/s11033-025-11385-3","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"30 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The Human Research Ethics Committee of the Habib Bourguiba University Hospital of Sfax approved the study protocol (protocol number of the ethical committee, 14\/2025).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"230"}}